Patexia Research

Case number 2:10-cv-05197

Lawsuits

CELGENE CORPORATION v. NATCO PHARMA LIMITED > Summary

Court Case Number 2:10-cv-05197

Filing Date Oct 8, 2010

Court New Jersey District Court

Status Unknown

Plaintiff

Defendant

3

Watson Laboratories

Arrow International, Inc.

Natco Pharma Ltd.

Plaintiff Attorneys

2

Celgene
Attorney Name: William C. Baton
Saul Ewing LLP

Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP

Defendant Attorneys

8

Arrow International, Inc.
Attorney Name: Melissa Steedle Bogad
Winston & Strawn

Natco Pharma Ltd.
Attorney Name: Melissa Steedle Bogad
Winston & Strawn

Watson Laboratories
Attorney Name: Melissa Steedle Bogad
Winston & Strawn

Arrow International, Inc.
Attorney Name: Jeffrey P. Catenacci
Winston & Strawn

Natco Pharma Ltd.
Attorney Name: Jeffrey P. Catenacci
Winston & Strawn

Watson Laboratories
Attorney Name: Jeffrey P. Catenacci
Winston & Strawn

Natco Pharma Ltd.
Attorney Name: James Richter
Winston & Strawn

Arrow International, Inc.
Attorney Name: James Richter
Winston & Strawn

Counter Defendant

3

Celgene
Attorney Name: William C. Baton
Saul Ewing LLP

Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP

Attorney Name: Andrew S. Chalson

Counter Claimant

10

Arrow International, Inc.
Attorney Name: Melissa Steedle Bogad
Winston & Strawn

Natco Pharma Ltd.
Attorney Name: Melissa Steedle Bogad
Winston & Strawn

Arrow International, Inc.
Attorney Name: Jeffrey P. Catenacci
Winston & Strawn

Natco Pharma Ltd.
Attorney Name: Jeffrey P. Catenacci
Winston & Strawn

Watson Laboratories
Attorney Name: Jeffrey P. Catenacci
Winston & Strawn

Natco Pharma Ltd.
Attorney Name: James Richter
Winston & Strawn

Humana Inc.
Attorney Name: James Richter
Winston & Strawn

Arrow International, Inc.
Attorney Name: James Richter
Winston & Strawn

Watson Pharma Private ltd
Attorney Name: James Richter
Winston & Strawn

Watson Laboratories
Attorney Name: James Richter
Winston & Strawn

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
07465800	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Dec 16, 2008
07119106	Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline	Oct 10, 2006
06755784	Methods for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated	Jun 29, 2004
06561976	Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug	May 13, 2003
06561977	Methods for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated	May 13, 2003
06555554	Isoindolines, method of use, and pharmaceutical compositions	Apr 29, 2003
06315720	Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug	Nov 13, 2001
06281230	Isoindolines, method of use, and pharmaceutical compositions	Aug 28, 2001
06045501	Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug	Apr 4, 2000
05635517	Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines	Jun 3, 1997